Researchers at Rush University Medical Center have found that opioid use might increase a person’s risk of developing pancreatic cancer.Read more
Henry Ford Health System today announced a $16 million gift to its Henry Ford Pancreatic Cancer Center (HFPCC), which was launched in 2018 by an initial $20 million gift from the same donor, who wishes to remain anonymous. The gift will bolster the HFPCC’s clinical and translational research endeavors in the fight against this devastating disease, for which the five-year survival rate is only 9 percent.Read more
A new approach to cancer therapy shows potential to transform the commonly used chemotherapy drug gemcitabine into a drug that kills cancer cells in a specialized way, activating immune cells to fight the cancer, according to a study led by Cedars-Sinai Cancer investigators.Read more
Longtime “Jeopardy!” host Alex Trebek announced it to the world on March 6, 2019: Like 50,000 other Americans each year, he had been diagnosed with stage 4 pancreatic cancer.Read more
Rutgers Cancer Institute of New Jersey expert addresses what you should know about pancreatic cancer including risks, symptoms and treatment.Read more
New research in the November 2020 issue of JNCCN identifies metastatic pancreatic cancer patient subgroups with the highest relative cost-effectiveness from maintenance olaparib, a PARP inhibitor.Read more
Pancreatic cancer often is hidden and doesn’t cause symptoms until it has spread. It is a leading cause of cancer deaths in the world.
November 19 is World Pancreatic Cancer Day, but the entire month of November is meant to bring awareness to this disease.
Advances in screening and early detection for high-risk people, minimally invasive surgical innovations and new genetic classifications are changing the outlook for pancreatic cancer, says Dr. Michael Wallace, a Mayo Clinic gastroenterologist.Read more
With the recent passing of Jeopardy host Alex Trebek, Rutgers Cancer Institute of New Jersey expert explains pancreatic cancer and the progress being made with this disease through research and clinical trials.Read more
In mourning of the death of Alex Trebek,Timothy Donahue, MD, chief of surgical oncology at UCLA’s Jonsson Comprehensive Cancer CenterRead more
Emily LaVoy, PhD, of the University of Houston, and colleagues explored the effects of moderate-intensity exercise on a mouse model of pancreatic cancer. Pancreatic cancer can be a particularly dangerous form of cancer because it is often diagnosed in later stages and spreads quickly. Though the trial sample was small—thus warranting further study—the results were optimistic.Read more
Pancreatic cancer cells avert starvation by signaling to nerves, which grow into dense tumors and secrete nutrients.Read more
A new analysis highlights the diversity of immune response in pancreatic cancer, and points toward the need for treatments tailored to individual patients.Read more